Phase II Trial of Weekly Intravenous Gemcitabine With Continuous Infusion Fluorouracil in Patients With Metastatic Renal Cell Cancer

2000155 citationsJournal Article

Authors

Brian I. Rini · Decatur Memorial Hospital

Nicholas J. Vogelzang · Decatur Memorial Hospital

M Dumas · Decatur Memorial Hospital

James L. Wade · Decatur Memorial Hospital

David Taber · Decatur Memorial Hospital

Walter M. Stadler · Decatur Memorial Hospital

Abstract

Weekly gemcitabine with continuous infusion 5-FU is an active combination in patients with metastatic RCC. Therapy was well tolerated and produced an improvement in progression-free survival over historical controls.

Topics & Keywords

Renal cell carcinoma treatment Pancreatic and Hepatic Oncology Research Cancer Genomics and Diagnostics

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Journal of Clinical Oncology

Volume 18, Issue 12, pp. 2419-2426

DOI: 10.1200/jco.2000.18.12.2419

Field-Weighted Citation Impact: 12.94